Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ventricular Assist Device Anti-Factor Xa (VAD ANTIX) Monitoring Study: a Prospective Randomized Feasibility Trial

NCT03143569 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT03143569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03143569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ventricular Assist Device Anti-Factor Xa (VAD ANTIX) Monitoring Study: a Prospective Randomized Feasibility Trial
Lead sponsor
Washington University School of Medicine
Phase
Not applicable
Overall status
Completed
Start date
May 20, 2017
Completion date
July 12, 2018
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anti-factor xa, anticoagulant therapy, aptt, gastro intestinal bleeding, heparin, left sided heart failure, left ventricular assist device, thrombosis, lvad